Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Overlake Hospital Medical Center

Below are some of the SCCA clinical trials now being offered for patients at Overlake Hospital Medical Center. If you have any questions about these or other trials, please contact Cancer Center at Overlake.

Breast Cancer (Newly Diagnosed)

Breast Cancer (Recurrent/Metastatic)

Colon Cancer (Newly Diagnosed/Recurrent)

Leukemia (Newly Diagnosed)

  • Vorinostat + Chemotherapy for CLL or SLL (PSOC-2401)
    A Phase I/II Study of Fludarabine (F), Cyclophosphamide ©), Rituximab ®), and Vorinostat (V) Followed by RV Maintenance Therapy in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small LymphoCtic Lymphoma (SLL)

Leukemia (Recurrent/Metastatic)

Lymphoma (Newly Diagnosed)

  • Vorinostat + Chemotherapy for CLL or SLL (PSOC-2401)
    A Phase I/II Study of Fludarabine (F), Cyclophosphamide ©), Rituximab ®), and Vorinostat (V) Followed by RV Maintenance Therapy in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small LymphoCtic Lymphoma (SLL)

Lymphoma (Recurrent/Metastatic)